Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma Matteo SantoniFrancesco MassariStefano Cascinu Review 17 October 2013 Pages: 1757 - 1768
CD8+ T-cell priming and boosting: more antigen-presenting DC, or more antigen per DC? Niels SchaftVerena WellnerJan Dörrie Original Article 10 October 2013 Pages: 1769 - 1780
Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions Raúl Germán SpallanzaniTomás Dalotto-MorenoNorberto Walter Zwirner Original Article 11 October 2013 Pages: 1781 - 1795
CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy Caspar KühnölMonique HerbarthChristof Kramm Original Article 16 October 2013 Pages: 1797 - 1809
Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer Giorgio MauriClaudia ChiodoniMario Paolo Colombo Original Article 18 October 2013 Pages: 1811 - 1819
Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy Saly Al-TaeiRussell BannerStephen Man Original Article 22 October 2013 Pages: 1821 - 1830
Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer Haydn Thomas KissickMartin George SandaMohamed Simo Arredouani Original Article 23 October 2013 Pages: 1831 - 1840
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC Shauna M. CollinsCourtney E. BakanDon M. Benson Jr. Original Article 26 October 2013 Pages: 1841 - 1849
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5–7, 2012 Michele MaioHugues Jean Marie NicolayGiorgio Parmiani Meeting Report 05 November 2013 Pages: 1851 - 1858
